Share Prices & Company Research

Market News

08 Mar 2021 | 08:25

Eco Animal Health expects FY revenues to be 'significantly ahead' of expectations

(Sharecast News) - Veterinary pharmaceuticals products manufacturer Eco Animal Health expects group revenues and underlying earnings for the year ending 31 March to be "significantly ahead" of both market expectations and the prior year.

Eco Animal said on Monday that continuing strength in the Chinese market, despite localised outbreaks of African swine fever, had led the group to record revenues in the Asian nation.

The AIM-listed group stated it had also delivered a strong performance in other territories, particularly in the USA.

Chief executive Marc Loomes said: "We are delighted that we will be trading ahead of market expectations and the current momentum that we are seeing in China with record revenues reflects the increasing demand for the group's flagship Aivlosin product line.

"We believe that our customers appreciate the superior performance of the group's products and we should not overlook the solid growth being experienced in most of the other geographical markets that ECO addresses."

As of 1135 GMT, Eco Animal shares were up 8.55% at 368.0p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.